However, this was mostly successful only in participants who were also obese
Sitagliptin works by inhibiting the DPP-4 enzyme that destroys glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) hormones, allowing both to function more effectively
The EVOKE trials enrolled nearly 4,000 patients, the largest, longest GLP-1 trials ever conducted in a neurodegenerative disease, Science noted, and showed no cognitive benefit despite improvements in some biomarkers
49 Global Burden of Disease Study 2013 Collaborators (2015)
Dosing Optimization and Personalization Standard dosing protocols provide starting points, but individualization often determines success
The idea behind oral-gut or chewable formats is that starting microbial contact in the mouth may support mucosal signaling